Suchergebnisse - "Franke, Fabio"

PubPharm (52)

1

RESILIENT Part 2 : A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Spigel, D. | Dowlati, A. | Chen, Y. | +115

2

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

3

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma : The Open-Label, Phase III PIVOT IO 001 Trial Results

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Diab, A. | Gogas, H. | Sandhu, S. | +23

4

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2023

von Wakelee, H. | Liberman, M. | Kato, T. | +117

CommentIn: Transl Lung Cancer Res. 2023 Nov 30;12(11):2359-2365. - PMID 38090512

5

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Chi, K. | Rathkopf, D. | Smith, M. | +118

CommentIn: J Clin Oncol. 2023 Jun 20;41(18):3291-3294. - PMID 36952642

6

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Kelley, R. | Ueno, M. | Yoo, C. | +119

CommentIn: Lancet. 2023 Jun 3;401(10391):1826-1827. - PMID 37075782

7

A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma

enthalten in: Cancer | 2022

von Munhoz, R. | Nader-Marta, G. | de Camargo, V. | +13

8

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Forde, P. | Spicer, J. | Lu, S. | +127

CommentIn: N Engl J Med. 2022 May 26;386(21):2050-2051. - PMID 35403840

9

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD) : a multicentre, open-label, phase 2 trial

enthalten in: The Lancet. Oncology | 2022

von Smith, M. | Scher, H. | Sandhu, S. | +117

10

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7 : A Phase III Randomized Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Lu, Y. | Im, S. | Colleoni, M. | +25

1
2
3
4
5
6
Nächster »
[6]